PLRX
Pliant Therapeutics, Inc.Company with tickers: PLRX
CIK
1746473
CUSIP
729139105
Shares Outstanding
61,920,249
13F Activity (30d)
85 filings
85 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $21,772,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Research & Development | $13,584,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-21,772,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-20,040,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.32 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.32 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |